Literature DB >> 19726737

Male germline and embryonic stem cell lines from NOD mice: efficient derivation of GS cells from a nonpermissive strain for ES cell derivation.

Hiroshi Ohta1, Yasuhide Ohinata, Masahito Ikawa, Yuka Morioka, Yuko Sakaide, Mitinori Saitou, Osami Kanagawa, Teruhiko Wakayama.   

Abstract

The nonobese diabetic (NOD) mouse is a valuable model for human type 1 diabetes and the development of humanized mice. Although the importance of this mouse strain is widely recognized, its usefulness is constrained by the absence of NOD embryonic stem (ES) lines with adequate germline transmission competence. In the present study, we established two germline transmission-competent types of cell lines from NOD mice; these cell lines, male germline stem (GS) cells and ES cells, were derived from NOD spermatogonia and blastocysts, respectively. NOD-GS cells proliferated in vitro and differentiated into mature sperm after transplantation into testis. NOD-ES cell lines were effectively established from NOD blastocysts using culture medium containing inhibitors for fibroblast growth receptor, MEK, and GSK3. Both the NOD-GS and NOD-ES cell lines transmitted their haplotypes to progeny, revealing a novel strategy for gene modification in a pure NOD genetic background. Our results also suggest that the establishment of GS cells is an effective procedure in nonpermissive mouse strains or other species for ES cell derivation.

Entities:  

Mesh:

Year:  2009        PMID: 19726737     DOI: 10.1095/biolreprod.109.079368

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  10 in total

Review 1.  Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.

Authors:  Jacob H Hanna; Krishanu Saha; Rudolf Jaenisch
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

2.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs.

Authors:  Jacob Hanna; Albert W Cheng; Krishanu Saha; Jongpil Kim; Christopher J Lengner; Frank Soldner; John P Cassady; Julien Muffat; Bryce W Carey; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-04       Impact factor: 11.205

Review 3.  Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes.

Authors:  Nick Holmes; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse.

Authors:  Timothy J Davies; Paul J Fairchild
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

5.  Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts.

Authors:  Jun Liu; Michelle P Ashton; Huseyin Sumer; Moira K O'Bryan; Thomas C Brodnicki; Paul J Verma
Journal:  Diabetes       Date:  2011-04-04       Impact factor: 9.461

6.  How are pluripotent cells captured in culture?

Authors:  Masaki Kinoshita
Journal:  Reprod Med Biol       Date:  2014-12-03

7.  Sleeping Beauty Transposon Mutagenesis as a Tool for Gene Discovery in the NOD Mouse Model of Type 1 Diabetes.

Authors:  Colleen M Elso; Edward P F Chu; May A Alsayb; Leanne Mackin; Sean T Ivory; Michelle P Ashton; Stefan Bröer; Pablo A Silveira; Thomas C Brodnicki
Journal:  G3 (Bethesda)       Date:  2015-10-04       Impact factor: 3.154

8.  Loss of Zbtb32 in NOD mice does not significantly alter T cell responses.

Authors:  William D Coley; Yongge Zhao; Charles J Benck; Yi Liu; Chie Hotta-Iwamura; M Jubayer Rahman; Kristin V Tarbell
Journal:  F1000Res       Date:  2018-03-14

9.  Improved establishment of embryonic stem (ES) cell lines from the Chinese Kunming mice by hybridization with 129 mice.

Authors:  Shumin Yu; Xingrong Yan; Huanhuan Liu; Xin Cai; Suizhong Cao; Liuhong Shen; Zhicai Zuo; Junliang Deng; Xiaoping Ma; Ya Wang; Zhihua Ren
Journal:  Int J Mol Sci       Date:  2014-02-25       Impact factor: 5.923

10.  Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology.

Authors:  Feng Li; Dale O Cowley; Debra Banner; Eric Holle; Liguo Zhang; Lishan Su
Journal:  Sci Rep       Date:  2014-06-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.